Stockwinners Market Radar for August 11, 2017 - Earnings, Upgrades downgrades, option trades, Best Stock Advisory Service |
AVA | Hot Stocks18:34 EDT Avista 'very disappointed' by Washington UTC's decision in PCRA filing - Avista's Power Cost Rate Adjustment filing was dismissed yesterday by the Washington Utilities and Transportation Commission. The PCRA filed by Avista on May 26, 2017 proposed an annual electric revenue increase of $15M or 2.9%, effective Sept. 1, 2017. This filing was separate from the electric and natural gas general rate cases also filed on May 26, 2017. This filing was made following meetings with Commissioners, Commission Staff and other parties involved in ratemaking proceedings, and was designed to be a starting point to get cost recovery back on track for Avista's Washington electric operations. The UTC's order in December 2016 provided no revenue increase for 2017, which has resulted in the electric rate increase request of 12.5% in Avista's pending general rate case in Washington to be higher than it otherwise would have been. The proposed PCRA increase was designed to make incremental progress with a 2.9% increase to customers Sept. 1, 2017, and a second-step increase effective at the conclusion of the general rate case on or around April 26, 2018. "We are very disappointed in the Commission's decision," said Scott Morris, Avista's Chairman, President and CEO. "The increased costs included in the PCRA were known changes in power costs, which have generally been less controversial in prior regulatory proceedings. The PCRA was an opportunity to begin to get retail rates back on track for customers, as well as provide some incremental improvement in earnings for the Company." Avista's power supply costs, on a normalized basis, are much higher than those built into base retail rates, and a revenue increase is needed to recover these increased costs on a going-forward basis. These increased costs are included in Avista's pending general rate case in Washington, which is scheduled to be concluded by April 26, 2018.
|
MTW | Hot Stocks18:30 EDT Manitowoc clarifies DLA contract announcement - The Manitowoc Company commented that the company was awarded a fixed-price with economic price adjustment contract SPE8EC-17-D-0008 from DLA with a maximum estimated value of $121.9M for procurement of commercial type cranes. This contract does not require the agency to order cranes from Manitowoc. The contract is a multiple award schedule-type contract that allows the services that use these cranes to place future delivery orders under the contract. The contract is active through August 10, 2022. This award is not to be confused with the US Army Type II Heavy Crane award announced on June 18, 2015.
|
ANFI | Hot Stocks17:40 EDT Amira Nature Foods names Varun Sethi as new CFO - Amira Nature Foods announced the appointment of Nathalie Dauriac as an independent director of the company and Varun Sethi as the new CFO. Bruce Wacha will step down as CFO effective August 21 upon effectiveness of Varun Sethi's appointment and will continue to serve as a director of the company. There was no dispute or disagreement between Wacha and the company on any matter relating to the company's accounting practices, financial statements.
|
NOC | Hot Stocks17:36 EDT Northrop Grumman, Aurora Flight Sciences awarded $499M government contract - Aurora Flight Sciences Corp., Manassas, Virginia; and Northrop Grumman Systems Corp., Redondo Beach, California, have been awarded a $499M indefinite-delivery/indefinite-quantity shared ceiling for six contracts for the Aerospace Systems Air Platform Technology Research program. These contracts provide research for affordable, revolutionary capabilities for the warfighter. Work will be performed in Manassas, Virginia; and Redondo Beach, California, and is expected to be completed by 2025. This award is the result of competitive acquisition and six offers were received. Fiscal 2017 research and development funds in the amount of $100,000 are being obligated to each company at time of award. Air Force Research Laboratory, Wright-Patterson Air Force Base, Ohio, is the contracting office.
|
LMT | Hot Stocks17:34 EDT Lockheed Martin awarded $8B government contract - Lockheed Martin Corp., Missiles and Fire Control, Lexington, Kentucky, has been awarded an $8B indefinite-delivery/indefinite-quantity contract for the Special Operations Forces Global Logistics Support Services requirement. The SOF GLSS contract shall provide non-personal, global logistics support services and expertise to maintain program support and Enterprise management functions for Program Executive Office of the Special Operations Forces Support Activity. This contract was a competitive acquisition, with five proposals received. U.S. Special Operations Command Contracting office, Tampa, Florida, is the contracting activity.
|
CSTR | Hot Stocks17:31 EDT Gaylon M. Lawrence, Jr. reports 6.2% stake in CapStar Financial
|
SBPH | Hot Stocks17:21 EDT Biotechnology Value Fund reports 5.1% passive stake in Spring Bank Pharma
|
VSI | Hot Stocks17:17 EDT Carlson Capital reports 4.97% stake in Vitamin Shoppe
|
FCB | Hot Stocks17:13 EDT FCB Financial names Jack Partagas CFO - FCB Financial Holdings announced the appointment of Jack Partagas to the position of CFO effective August 31, 2017. He will succeed Jennifer Simons who will remain with the company and transition into the role of Operations Director. Simons will work closely with Partagas to assist with the transition of the CFO responsibilities and thereafter lead a number of operational disciplines within the company.
|
PBPB | Hot Stocks17:11 EDT Potbelly names Peter Bassi chairman of the board - According to a regulatory filing, on August 9, 2017, the board of directors of Potbelly Corporation appointed Peter Bassi, who at that time served as lead director of the company, to succeed Aylwin Lewis as chairman of the board of directors. As previously reported on Form 8-K, filed with the Securities and Exchange Commission on May 31, 2017, Lewis resigned from his position on the board of directors and as chairman of the board of directors effective August 8, 2017.
|
RYAM | Hot Stocks17:01 EDT Rayonier Advanced Materials, Tembec receive MOFCOM clearance - Rayonier Advanced Materials and Tembec announced that they received notification from the Anti-Monopoly Bureau of the Ministry of Commerce of the People's Republic of China, or MOFCOM, that it has cleared, without condition, the previously announced proposed statutory arrangement under Section 192 of the Canada Business Corporations Act involving the acquisition by Rayonier Advanced Materials of all of the outstanding shares of Tembec.
|
LOGI | Hot Stocks17:01 EDT Logitech closes acquisition of ASTRO Gaming - Logitech announced that it has closed its acquisition of ASTRO Gaming, a leading console gaming brand with a history of producing award-winning headsets for professional gamers and enthusiasts. Logitech first announced its agreement to acquire ASTRO in July 2017, as the company invests in an adjacent gaming market - the console gaming market.
|
MULE | Hot Stocks16:42 EDT Gilder, Gagnon reports 2% passive stake in MuleSoft
|
GLBL | Hot Stocks16:42 EDT TerraForm Global COO Studebaker, interim CAO Rawden resign - According to a regulatory filing, on August 9, 2017, Thomas Studebaker resigned as Chief Operating Officer of TerraForm Global, Inc. and David Rawden resigned as Interim Chief Accounting Officer of TerraForm Global. Studebaker and Rawden had been appointed as officers of TerraForm Global, effective July 7, 2016, as part of TerraForm Global's engagement of AP Services, a subsidiary of AlixPartners, for certain consulting services.
|
LAD | Hot Stocks16:39 EDT Sidney DeBoer lowers stake in Lithia Motors to 4.7%
|
TERP | Hot Stocks16:33 EDT TerraForm Power announces receipt of Nasdaq letter - TerraForm Power announced that on August 10, it received a notification letter from a Senior Director of Nasdaq Listing Qualifications. The Notification Letter stated that because the company has not yet filed its Form 10-Q for the quarter ended June 30, 2017, this serves as an additional basis for delisting the company's securities from the Nasdaq Stock Market under Nasdaq Listing Rule 5250(c)(1), which requires timely filing of periodic reports with the SEC. The Notification Letter has no immediate effect on the listing of the Company's Class A common stock on the Nasdaq Global Select Market. The Company continues to work to regain compliance with Nasdaq's continued listing requirements as soon as practicable. However, there can be no assurance that the Company will file its Forms 10-Q for the first and second quarters of 2017 and regain compliance with Nasdaq's continued listing requirements on or before the respective deadlines.
|
ISRG | Hot Stocks16:13 EDT Intuitive Surgical board approves a three-for-one stock split - Intuitive announced that its board has approved a three-for-one split of the company's common stock to be effected through an Amendment to the company's certificate of incorporation. Implementation of the stock split is subject to stockholder approval of the amendment to the certificate of incorporation at the special meeting of stockholders, which is currently scheduled to take place on September 22. Additional details regarding the special meeting of stockholders and the proposed amendment to the certificate of incorporation will be included in a proxy statement scheduled to be distributed to stockholders on or about August 30. Subject to stockholder approval of the amendment to the certificate of incorporation, each Intuitive stockholder of record at the close of business on the record date of September 29, will receive two additional shares for every one share held on the record date, and trading will begin on a split-adjusted basis on October 6.
|
AZRX | Hot Stocks15:28 EDT AzurRx BioPharma reports sublicense agreement with TransChem - In a regulatory filing, AzurRx Biopharma reported that the company entered into a sublicense agreement with TransChem, pursuant to which TransChem granted to the company an exclusive license to patents and patent applications relating to Helicobacter pylori 5'-methylthioadenosine nucleosidase inhibitors currently held by TransChem. Unless terminated earlier under the provision of the sublicense agreement, the agreement will expire upon the expiration of the last agreement patent. The company paid an upfront signing fee to TransChem and agreed to reimburse TransChem for certain expenses previously incurred in connection with the preparation, filing and maintenance of the agreement patents. The company also agreed to pay to TransChem periodic sublicense maintenance fees, which, in the event the company becomes obligated to pay certain royalties under the agreement, such fees may be credited against those royalties. In addition to the sublicense maintenance fees, the company may be obligated to pay to TransChem additional payments and royalties in the future, in the event certain performance-based milestones and commercial sales involving the agreement patents are achieved.
|
NUTR | Hot Stocks15:21 EDT Weiss Asset Management reports 8.76% passive stake in Nutraceutical
|
BMI | Hot Stocks14:47 EDT Badger Meter increases dividend 13% to 13c per share - Badger Meter announced a 13% increase in its quarterly common stock dividend to 13c per share from 11.5c per share. The increased dividend is payable September 15 to shareholders of record August 31.
|
OGXI | Hot Stocks14:19 EDT Robert Schacter reports 16.7% passive stake in Achieve Life Sciences
|
CMTA | Hot Stocks13:44 EDT OrbiMed reports 34.15% stake in Clementia Pharmaceuticals
|
BHGE | Hot Stocks13:13 EDT Baker Hughes reports U.S. rig count down 5 to 949 - Baker Hughes reports that the U.S. Rig Count is down 5 rigs from last week to 949, with oil rigs up 3 to 768 and gas rigs down 8 to 181. The U.S. Rig Count is up 468 rigs from last year's count of 481, with oil rigs up 372, gas rigs up 98, and miscellaneous rigs down 2 to 0. The U.S. Offshore Rig Count is up 1 rig from last week to 18 and up 1 rig year over year. The Canadian Rig Count is up 3 rigs from last week to 220, with oil rigs up 3 to 127 and gas rigs unchanged at 93. The Canadian Rig Count is up 94 rigs from last year's count of 126, with oil rigs up 62, gas rigs up 33, and miscellaneous rigs down 1 to 0.
|
BHGE | Hot Stocks13:05 EDT Baker Hughes reports U.S. rig count down 5 to 949 - Baker Hughes reports that the U.S. rig count is down 5 rigs from last week to 949. The Canadian rig count is up 3 from last week to 220 rigs and the international rig count is down one from last week to 959.
|
TWX... | Hot Stocks12:52 EDT Box Office Battle: 'Annabelle: Creation' expected to take top spot - Opening this weekend, and expected to take the top spot at the box office, is Time Warner's (TWX) Warner Bros. horror sequel "Annabelle: Creation," which is expected to open domestically in the $30M-$35M range. "Annabelle: Creation" already brought in $4M from Thursday night previews. Expected to finish in second place for the second week in a row is Warner Bros. "Dunkirk," Christopher Nolan's non-linear World War II film, which is expected to earn an additional $11M-$12M in its fourth weekend at theaters. Also opening this weekend is Open Road's animated "The Nut Job 2: Nutty by Nature," which is expected to open in the $9M-$12M range. Open Road is a joint venture between AMC (AMC) and Regal Entertainment (RGC). Comcast (CMCSA, CMCSK) subsidiary Universal's female-led comedy "Girls Trip," starring Regina Hall, Tiffany Haddish, Jada Pinkett Smith and Queen Latifah, is expected to earn an additional $7M-$8M in its fourth weekend at theaters. Sony's (SNE) fantasy epic "The Dark Tower," based on the Stephen King novels and starring Matthew McConaughey and Idris Elba, is expected to earn $7M-$8M in its second weekend at theaters, after winning the box office last weekend. Other publicly traded companies in filmmaking include 21st Century Fox (FOX, FOXA), Disney (DIS), Lionsgate (LGF.A, LGF.B), and Viacom (VIA, VIAB).
|
ATVI... | Hot Stocks12:47 EDT Game publishers rise as Piper notes eSports growth potential - Shares of video game makers were trading higher after an analyst from Piper Jaffray discussed in a research note the growth prospects of the Electronic Sports industry, noting that the phenomenon has "significant growth potential" despite some early skepticism. ESPORTS POTENTIAL: Piper Jaffray analyst Michael J. Olson said that the eSports sector has significant growth potential, noting that the majority of eSports revenue presently is from sponsorships and advertising as companies seek to target to a hard-to-reach demographic that is generally not as well captured in traditional sports advertising. Olson said that, for public video game publishers such as Activision Blizzard (ATVI), Electronic Arts (EA), and Take-Two (TTWO), the opportunity from eSports over the next 1-2 years will primarily be tied to a "marketing halo" created by events that utilize these game makers' titles. Over the long term, Olson said he sees potential for additional revenue from broadcast rights, advertising, sponsorships, live events and more, but this would be additive to current Wall Street estimates, as opposed to being already baked into analyst models. The analyst said that total revenue from eSports is expected to surpass $1B in 2017, with a global audience of over 200M gamers. WHAT'S NOTABLE: Activision Blizzard has more titles among the top eSports titles than any other publisher, and the company has been investing in leagues and platforms, Olson said. According to the Piper note, Activision Blizzard, which is comprised of Activision Publishing and Blizzard Entertainment, is responsible for four of the top eight games in eSports, namely "Call of Duty," "Overwatch," "StarCraft II," and "Heroes of the Storm." Meanwhile, Electronic Arts has shifted focus on using eSports as a driver for engagement, with several competitions tied to its traditional sports games, the analyst said. Notably, at this year's E3 conference this past June, EA centered much of its presence at the event on demonstrating the competitive gaming aspects of its upcoming release "Star Wars Battlefront II." In addition, Olson noted that Take-Two intends to enter the eSports sector this year with its basketball simulation series "NBA 2K." Piper maintained an Overweight rating on all three stocks. PRICE ACTION: In early afternoon trading, Activision Blizzard was up 0.9%, EA rose 1.4%, and Take-Two was trading 1.4% higher.
|
USM | Hot Stocks11:41 EDT U.S. Cellular CFO sells 18K shares of company stock - U.S. Cellular CFO Steven Campbell disclosed in a filing that he had sold 18,292 shares of company stock at an average price of $39.95 per share on August 9. The total transaction value was $730,851. Shares of U.S. Cellular are trading relatively flat this morning at $38.84.
|
KR... | Hot Stocks11:31 EDT Sell Kroger given challenges facing conventional grocers, says Stephens - Research firm Stephens started coverage of grocery store chain Kroger (KR) with an Underweight rating, its equivalent of a sell rating. The firm initiated coverage of Kroger's competitor Sprouts Farmers Market (SFM) with a neutral equivalent and also began coverage of a retailer and supplier to the space, United Natural Foods (UNFI). KROGER: The company has "one of the best management team in...food retail," and its operations are "best-in-class," wrote Stephens analyst Ben Bienvenu. However, its status as a price competitive conventional grocer will weigh on its financial results in the near-term, the analyst stated. Increasing price competition and higher labor costs could also hurt its results, Bienvenu believes. He placed a $20 price target on the shares. UNITED NATURAL: The increasingly widespread availability of natural and organic food at "numerous grocery channels" will weigh on United Natural Foods' results, warned Bienvenu. Whole Foods' (WFM) struggles will also hurt United Natural's results, he stated, adding that Amazon's (AMZN) purchase of Whole Foods increases the risk facing United. He set a $40 price target on the shares. SPROUTS: The chain's products and "price position" are among the best in the market, Bienvenu stated. However, the stock's valuation reflects the company's strengths as well as a possible takeover, contends the analyst, who set a $25 price target on the name. PRICE ACTION: In morning trading, Kroger rose fractionally to $23.50, United Natural was down fractionally at $36, and Sprouts gained 0.5% to about $24 per share.
|
RDUS | Hot Stocks11:22 EDT Radius Health holder Biotech Growth buys 150,000 shares - Biotech Growth bought 150,000 shares of Radius Health over August 9 and 10, according to a regulatory filing.
|
GLBL | Hot Stocks11:20 EDT Gardner Lewis reports new 5.5% stake in TerraForm Global
|
NVDA... | Hot Stocks10:40 EDT Nvidia pullback after Q2 beat called a 'gift' by bulls - Nvdia (NVDA) yesterday reported stronger than expected results but its stock fell as its datacenter revenue came in below expectations. Moreover, the beat was seen by many as being driven by the company's cryptocurrency business, which is generally viewed as quite volatile. However, a number of firms were upbeat on the stock, with Citi calling the pullback in the shares a "gift" and Jefferies recommending that investors buy the shares on weakness. Nomura Instinet, a rare bear on the stock, raised its target but still sees the shares having a large amount of downside potential. BULLISH TAKE: Citi analyst Atif Malik called the weakness in Nvidia's stock "a gift," suggesting that the company's datacenter business may have been hindered last quarter by the transition to its new Volta chip. Noting that Nvidia expects its revenue from datacenters to rise this quarter, the analyst says that the chip maker can "easily" beat the Street's prior datacenter revenue estimate for the quarter of $466M. The analyst continues to expect the company to benefit from strength in its datacenter, gaming and auto businesses this year, and he raised his price target on the stock to $185 from $180 while keeping a Buy rating on the shares. Also upbeat on Nvidia was Jefferies analyst Mark Lipacis, who recommended that investors buy the stock on weakness. The company's datacenter business should resume growing at a "healthy" rate as Volta is evaluated and then adopted by multiple customers, the analyst explained. He continues to expect the company to benefit from the shift to "parallel processing architectures." Lipacis kept a $180 price target and a Buy rating on the shares. MORE CAUTIOUS: Stifel analyst Kevin Cassidy called Nvidia's results "solid," but he believes that some investors could be disappointed that "much" of the company's "revenue beat...came from the highly volatile crytocurrency market and not from datacenters' adoption" of Nvidia's chips. Calling datacenter revenue "notoriously lumpy," the analyst still expects Nvidia's revenue from datacenters to rise 15%-20% annually over the longer term. Cassidy raised his price target on the shares to $110 from $93 but kept a Hold rating on the stock based on valuation. Nvidia reported "impressive" results, and its datacenter business should accelerate as Volta becomes more widely available this quarter, wrote Roth Capital's Brian Alger. He said Nvidia's performance over the past several quarters has made it clear that neither Intel (INTC) nor AMD (AMD) have been able to slow the company's growth, leaving it "alone" among semiconductor companies in terms of big volume and big dollar growth potential. However, the analyst "struggles" with predicting that the stock's current valuation will rise significantly further. Alger raised his price target on Nvidia to $150 from $120, but kept a Neutral rating on the shares. RARE BEAR: Nomura Instinet analyst Romit Shah said Nvidia continues to see "subdued" trends in core PC gaming, minimal gross margin leverage and decelerating revenue and earnings growth. Shah believes shares remain overvalued and reiterates his Reduce rating, though he raised his price target on the stock to $110 from $90. PRICE ACTION: In morning trading, Nvidia fell 5% to $156.45.
|
MFA | Hot Stocks10:24 EDT MFA Financial co-CEO William Gorin passes away
|
BCS CS | Hot Stocks10:24 EDT Stephen Dainton hired by Barclays as head of equities, Reuters reports - Stephen Dainton, who previously worked at Credit Suisse (CS) as its co-head of global markets for Europe, the Middle East and Africa, has been hired by Barclays (BCS) to become its global head of equities, Reuters reports. Dainton will join Barclays in early September and report to Barclays investment banking chief Tim Throsby. Reference Link
|
JCP... | Hot Stocks10:13 EDT Retail wreckage continues with J.C. Penney report, dragging Nordstrom lower - Shares of J.C. Penney (JCP) added to the retail wreckage of the last few days after reporting a larger than expected loss for the latest quarter, adding to concerns about the broader sector following disappointing reports yesterday from peers Macy's (M) and Kohl's (KSS). Separately, higher-end peer Nordstrom (JWN) bucked the trend of declining sales in the sector, reporting a comparable store sales gain for its latest quarter and raising guidance. While Nordstrom shares briefly went into the green, they declined following the market open as the sector gives back some of the gains seen in the run-up to this week's reports. J.C. PENNEY: J.C. Penney reported an adjusted loss per share for the second quarter of (9c), compared to forecasts for a (5c) loss. Comp sales slid 1.3%, falling below the retailer's fiscal year guidance. The comp sales decline for the quarter resulted in a positive two-year stack of 0.9%, the company said. Despite misses on the EPS and comp sales lines, revenue of $2.96B beat forecasts of $2.84B. CEO Marvin Ellison said that while the broader retail sector "remains challenged," all categories delivered improved sales results during the quarter, with beauty, home refresh and omnichannel continuing to deliver positive sales growth. On the company's earnings call, Ellison said there was greater margin and EPS dilution than expected during the quarter following the liquidation of inventory in 127 closing stores, but said he believes this was "isolated" to Q2. Looking ahead, J.C. Penney backed its guidance for fiscal 2017 adjusted EPS of 40c-65c and SSS down 1%-up 1% and said it expects improved results in the back half of the year. Ellison said that July's sales trend has carried into the early back-to-school season. NORDSTROM: Nordstrom, meanwhile, yesterday reported EPS of 65c, beating analysts' estimates of 64c, and total revenue of $3.79B also beat the $3.75B consensus. Comp sales for the quarter were up 1.7% compared to last year and followed an 0.8% decline last quarter. Nordstrom raised its FY17 adjusted EPS view to $2.85-$3.00 from $2.75-$3.00, revenue growth view to roughly 4% from 3%-4% and backed its SSS growth view of approximately flat. Nordstrom said that its recent Anniversary Sale, historically its largest event of the year, performed better than recent trends. WHAT'S NOTABLE: Mall-based retailers have been hurt by the increasing popularity of fast-fashion retailers like Zara, Forever 21 and H&M, as well as an increase in online shopping. Nordstrom said in June that members of its founding family formed a group to explore the possibility of pursuing a "going private" transaction, but Women's Wear Daily recently said that the retailer is not in negotiations with "anybody" regarding a potential sale. Talks continue with potential parties to a deal, though they are described as informal, the report noted. PEERS: Yesterday, sector peer Macy's (M) sunk after reporting another quarter of declining comps, though its EPS and revenue were above analysts' estimates. While Macy's backed its guidance for FY17, it forecast third quarter comp sales on an owned plus licensed basis down 2.5% "or worse" and fall season comp sales on an owned plus licensed basis to be down 0.8% to down 2.6%. Gross margin for the year is expected to be down 50-70bps vs. last year, better than previous guidance. CFO Karen Hoguet said that there was "not a lot new" on Macy's real estate initiatives since June's investor meeting and that work on its Herald Square location "continues." Kohl's also reported earnings yesterday, with EPS and revenue narrowly beating estimates, though its comp sales declined 0.4% from the year ago period. "The traffic momentum that we saw in the combined March/April period accelerated in the second quarter," CEO Kevin Mansell said in a statement. "Though transactions for the quarter were lower than last year, July transactions increased. We are also excited by the sequential sales trend improvement in all our lines." Kohl's said it is "on track" to achieve its financial goals for the year. On its earnings call, Mansell reiterated that Kohl's sees an opportunity to capture sales from competitors' stores that are closing, which may include closing stores from Macy's and J.C. Penney. Another peer, Dillard's (DDS), also reported earnings yesterday, reporting much weaker than expected EPS on sales that missed estimates. CEO William Dillard, commented that "Significant markdowns led to a disappointing loss as we dealt with inventory, which was up 2% at quarter end." ANALYST COMMENTARY: Credit Suisse analyst Christian Buss said this morning that "continued caution is in order" following J.C. Penney's Q2 report, as he sees core operating profitability declining and underlying demand still being "tepid." UBS analyst Michael Binetti said that while Macy's results were better than expected, guidance for the second half has damaged confidence that positive trends are sustainable. The analyst maintained his Neutral rating on Macy's but cut his price target to $21 from $23. Meanwhile, Kohl's was upgraded to Hold from Reduce at Gordon Haskett and to Neutral from Underperform at Credit Suisse. PRICE ACTION: In morning trading, J.C. Penney is off earlier lows, but still down 17% to $3.91, while Nordstrom is down 2% to $44 per share.
|
BGI | Hot Stocks09:35 EDT Birks Group trading resumes
|
CHKP | Hot Stocks09:30 EDT Check Point announces extension to share repurchase program - Check Point announced that its board has authorized an extension to the company's on-going share repurchase program. Under the updated plan, effective immediately, Check Point is authorized to continue to repurchase up to $250 million of ordinary shares each quarter, up to an aggregate of $1 billion. From April 1, 2016 through June 30, 2017, Check Point repurchased approximately 14 million shares for an aggregate purchase price of approximately $1.2 billion, which represented an average repurchase per quarter of $247.3 million. As of June 30, 2017, Check Point has approximately 162.8 million ordinary shares outstanding. Check Point began its share repurchase program in 2003, and since then has repurchased approximately 144.9 million shares for a total purchase price of approximately $6.3 billion. The updated plan extends the previous repurchase plan adopted in May 2016, which provided for the repurchase of up to $250 million shares each quarter, up to an aggregate of $1.5 billion.
|
TTD... | Hot Stocks09:21 EDT On The Fly: Pre-market Movers - UP AFTER EARNINGS: Trade Desk (TTD), up 7.9%... Aegean Marine (ANW), up 9.4%... Nordstrom (JWN), up 1.5%. DOWN AFTER EARNINGS: Snap (SNAP), down 10.9%... J.C. Penney (JCP), down 18.5%... NVIDIA (NVDA), down 4.4%.
|
GM | Hot Stocks09:19 EDT GM Financial launches retail term notes program - GM Financial announced the launch of GM Financial Term Notes, a program targeted to retail investors that offers medium-term notes through broker-dealers and registered investment advisers. The notes will be issued on a periodic basis, beginning in the third quarter of 2017. GM Financial Term Notes will be issued at par value, at competitive market-based rates. Maturities will range from nine months to 30 years. Unless otherwise stated, the notes will contain a "survivor's option" feature providing for repayment prior to maturity in the event of the beneficial owner's death, and issuances will have a minimum investment of $1,000. The specific terms of each series of notes will be set prior to the time of sale and will be described in a publicly available pricing supplement.
|
NAII | Hot Stocks09:18 EDT Natural Alternatives' CarnoSyn beta-alanine included in Indur workout formula - Natural Alternatives International and Indur, a health and wellness lifestyle and products company, announced the inclusion of the full daily dose of SR CarnoSyn sustained release beta-alanine in Indur's newly released workout accelerator product, Indur Launch. Beta-alanine combines with histidine in the body to form carnosine, which acts as a buffer and helps to delay the onset of muscle fatigue and failure.
|
CAT | Hot Stocks09:16 EDT Caterpillar names Suzette Long as general counsel, corporate secretary - Caterpillar announced its board of directors has appointed Suzette Long as the company's general counsel and corporate secretary. Long has provided interim leadership to Caterpillar's Law and Public Policy group since mid-February. The group she will lead includes Caterpillar's Legal Services Division and Global Government & Corporate Affairs Division. Long will also be Caterpillar's corporate secretary.
|
BGI | Hot Stocks09:16 EDT Birks Group to sell Mayor's Jewelers to Aurum Holdings for $104.6M - Birks Group announced that it has signed a definitive agreement to sell its subsidiary, Mayor's Jewelers to Aurum Holdings, a fine watch and jewelry retailer in the U.K., in a deal valued at approximately $104.6M. The transaction is subject to specified closing conditions and purchase price adjustments. The transaction is expected to close in the fall of 2017. As part of the transaction, Birks entered into a 5 year distribution agreement with Aurum to sell Birks fine jewelry in the U.K. at Mappin & Webb, Goldsmiths stores and on their e-commerce sites. Furthermore, the Birks collections will continue to be sold in the United States through Mayors' stores in Florida and Georgia. Proceeds from the transaction will be used by Birks to continue its strategic growth initiatives, specifically to invest in its Canadian flagship stores and new store concepts, as well as in its high-growth Birks brand wholesaling activities and e-commerce, as part of the Company's omni-channel plan. Transaction proceeds will also be used to pay down outstanding debt under the Company's senior secured credit facilities that include term debt and working capital debt associated with Mayors. Centered on Birks distinguished 138-year heritage, these investments are expected to accelerate revenue and EBITDA growth over the next few years.
|
JCP | Hot Stocks09:09 EDT J.C. Penney: Store closures putting company in better inventory position - Ellison said he is "pleased" with J.C. Penney's ongoing partnership with Sephora. New CFO Jeff Davis noted that store closures put company in a better inventory position. Expects net debt to EBITDA ratio to be 3x by end of year. Ellison said that Fenty Beauty by Rihanna will launch later this quarter and will be exclusive to both Sephora and Sephora Inside JCPenney. By the end of the year, J.C. Penney expects to have nearly 650 Sephora locations.
|
JCP | Hot Stocks09:02 EDT J.C. Penney CEO: Easiest comparisons are in 2H
|
DLR | Hot Stocks09:01 EDT Digital Realty COO Jarrett Appleby departing mid-September - Digital Realty COO Jarrett Appleby will be leaving the company to pursue other opportunities, effective September 15. The company has initiated a search for a new COO and expects to retain an executive search firm to assist with the search. Members of Digital Realty's management team will assume Appleby's duties in the interim until a successor is identified.
|
NDSN | Hot Stocks09:01 EDT Nordson board increases dividend 11% to 30c per share - Nordson announced that its Board of Directors has approved an increase in the company's quarterly cash dividend to 30c per common share from 27c, an increase of 11%. The dividend is payable on September 5, 2017 to shareholders of record as of the close of business on August 22, 2017 and represents a total distribution to shareholders of approximately $17.3M.
|
BGI | Hot Stocks08:47 EDT Birks Group trading halted, news pending
|
JCP | Hot Stocks08:43 EDT J.C. Penney: July's sales trend has carried into early BTS selling season - Chairman and CEO Marvin Ellison said on the company's Q2 earnings conference call that J.C. Penney had positive comps in May, low single digit negative comps in June and approximately flat comps in July. Ellison said the sales trend in July has carried into the early back-to-school selling season. Ellison noted that omnichannel was "a big win" in Q2. He also said that there was much greater margin dilution that expected in Q2 following the liquidation of stores, believes this is isolated to Q2. He added that Q2 was a "unique quarter" based on the large number of liquidated stores. There has been no negative impact to ecommerce in zip codes where stores have closed, Ellison said. J.C. Penney is down over 23% in premarket trading.
|
JCP | Hot Stocks08:40 EDT J.C. Penney: July's sales trend has carried into early BTS selling season - Chairman and CEO Marvin Ellison said on the company's Q2 earnings conference call that J.C. Penney had positive comps in May, low single digit negative comps in June and approximately flat comps in July. Ellison said the sales trend in July has carried into the early back-to-school selling season. Ellison noted that omnichannel was "a bit win" in Q2. He also said that there was much greater margin dilution that expected in Q2 following the liquidation of stores, believes this is isolated to Q2. He added that Q2 was a "unique quarter" based on the large number of liquidated stores. There has been no negative impact to ecommerce in zip codes where stores have closed, Ellison said. J.C. Penney is down over 23% in premarket trading.
|
PPHM | Hot Stocks08:35 EDT Peregrine reduced overall workforce by 20%, sees FY18 cost savings $3.7M-$4.3M - Peregrine Pharmaceuticals announced that it has reduced its overall workforce by 60 employees, or 20%, as part of its series of planned strategic actions to reduce costs and better position the company to achieve overall profitability while it pursues strategic options for its research and development assets. The company expects the workforce reductions to result in a net cost savings of between $3.7M-$4.3M in FY18 and more than $7M in reduced annualized operating expenses beginning in FY19. As part of the cost saving initiatives, the company reduced Peregrine's R&D personnel by 50% to 11 employees, with the remaining staff supporting potential strategic alternatives for its R&D assets while continuing to assist with collaborative trials, the antibody discovery platform, and the exosome program. Personnel supporting the Avid Bioservices CDMO business, a wholly owned subsidiary of Peregrine Pharmaceuticals, was reduced by 20% to 184 employees to align operations with the reduction in forecasted revenues. In addition, selling, general and administrative personnel was reduced by 8% to 49 employees as the company continues to pursue leaner support operations. The charge to earnings for these personnel reductions will be between $1.1M-$1.7M, all of which is expected to be incurred during Q2 of FY18. Last month, Peregrine announced that as part of its strategic review it intends to expand its board of directors to add new members with CDMO and biologics experience and to commence a search for a dedicated president to head its Avid CDMO business.
|
RLJE | Hot Stocks08:34 EDT RLJ Entertainment acquires Brawl In Cell Block 99 - RLJ Entertainment's RLJE Films brand has acquired all North American rights to the film Brawl In Cell Block 99. Los Angeles-based XYZ Films will handle foreign sales and serve as executive producers on the project. The film stars Vince Vaughn, Jennifer Carpenter, Marc Blucas, Udo Kier and Don Johnson. The film will make its World Premiere at the 2017 Venice International Film Festival and will continue on to screen at the 2017 Toronto International Film Festival and Fantastic Fest. RLJE Films plans to release Brawl In Cell Block 99 in theaters on Oct. 6.
|
BHAC | Hot Stocks08:33 EDT Barington/Hilco Acquisition holders approve extension date of combination - Barington/Hilco Acquisition announced that stockholders have approved an extension of the date by which it must complete a business combination. The extension allows the company until December 31, 2017 to complete a business combination. Following redemptions associated with the Extension, a total of approximately $15 million will remain in the company's trust account. In connection with the Extension, the Company's sponsors agreed to contribute to the Company as a loan $0.025 for each public share that was not converted in connection with the stockholder vote to approve the Extension, for each 30-day period, or portion thereof, that is needed by the company to complete a business combination. This will increase the pro rata portion of the funds available in the trust account in the event of the consummation of a business combination or a liquidation from approximately $10.36 per share to approximately $10.48 per share, assuming the company takes the full time through December 31, 2017 to complete a business combination. On May 12, 2017, the company entered into a merger agreement with Oomba, a specialized social media and software development company. The purpose of the Extension is to provide Oomba additional time to complete an audit of its financial statements so that the parties may proceed with closing the transactions contemplated by the Merger Agreement.
|
DRYS | Hot Stocks08:30 EDT Dryships trading resumes
|
VMET | Hot Stocks08:28 EDT Viamet study data demonstrates 'unprecedented' results in RVVC treatment - Viamet Pharmaceuticals announced the presentation of results from REVIVE, a Phase 2b clinical trial of VT-1161 in the treatment of patients with recurrent vulvovaginal candidiasis, at the Infectious Diseases Society for Obstetrics and Gynecology Annual Meeting in Park City, Utah. VT-1161 is a highly potent and selective, orally-administered inhibitor of fungal CYP51 that has demonstrated broad-spectrum activity against yeast, dermatophyte, endemic and multi-drug resistant fungal pathogens. The REVIVE study, presented by Jack Sobel, M.D., during an oral presentation on Thursday, August 10, demonstrated unprecedented efficacy and safety in patients with RVVC, a condition associated with a very high burden of disease and for which there are no approved therapies. The presentation titled, "Results from a Phase 2, Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Evaluate the Efficacy and Safety of VT-1161 Oral Tablets in the Treatment of Patients with Recurrent Vulvovaginal Candidiasis," was delivered by Dr. Sobel. In the intent-to-treat population, defined as all randomized subjects, the proportion of subjects with one or more vulvovaginal candidiasis episodes through 48 weeks ranged from 0-7% in the VT-1161 arms compared to 52% in the placebo arm. In the per protocol analysis, which included patients evaluable through 48 weeks, the recurrence rate of one or more vulvovaginal candidiasis episodes in the placebo arm was 66% while the four VT-1161 arms ranged from 0-11%. Throughout the study, VT-1161 was very well tolerated and there was a lower incidence of adverse events reported in all VT-1161 arms compared to placebo. VT-1161 also showed no evidence of adverse effects on laboratory parameters, which have been an issue for other oral treatment approaches for RVVC. In addition, VT-1161 displayed potent activity against a range of Candida species including C. glabrata, which is becoming more pronounced and which has shown resistance to other antifungal agents such as fluconazole.
|
JCP ADDYY | Hot Stocks08:18 EDT J.C. Penney backs FY17 free cash flow view of $300M-$400M - J.C. Penney (JCP) says women's Adidas (ADDYY) apparel now in over 400 stores for back-to-school season. Says has expanded ship from store fulfillment strategy to 100% of store network and implemented free ship-to-store with no minimum threshold. Comments from slides that will be presented on the Q2 earnings conference call.
|
EROS | Hot Stocks08:15 EDT Eros International's Eros Now partners with Opera TV - Eros International announced that Eros Now, its digital over-the-top South Asian entertainment platform, will now be available on all Opera TV powered devices including smart TVs, Blu-ray disc players and set-top boxes worldwide. Subscribers will also be able to access Eros Now using the Opera TV store.
|
ANDV | Hot Stocks08:08 EDT Andeavor receives sufficient commitments to construct Conan pipeline system - Andeavor announced that it received sufficient commitments from third party shippers to warrant construction of the Conan Crude Oil Gathering Pipeline system in the Delaware Basin. As previously announced, the Conan Crude Oil Gathering Pipeline system will be approximately 130 miles in length and transport crude oil from origins in Lea County, New Mexico and Loving County, Texas to a terminal to be constructed in Loving County, Texas, where the gathering system interconnects with long-haul pipeline carriers. The first phase of the Conan Crude Oil Gathering Pipeline system will provide capacity of approximately 250,000 barrels per day. Future phases of the system may expand capacity up to 500,000 barrels per day. The system is under construction and is expected to begin commercial service in mid-2018. The estimated capital investment for the first phase of the gathering system is approximately $225 million of which $75 million is expected to be spent in 2017.
|
DRYS | Hot Stocks08:05 EDT DryShips announces termination of stock purchase agreement with Kalani - DryShips announces that in connection with the transactions announced earlier, (i) it has terminated the common stock purchase agreement, dated April 3 by and between the company and Kalani Investments Limited, a company organized and existing under the laws of the British Virgin Islands, effective immediately; (ii) George Economou, the company's Chairman and CEO, has agreed, either directly or through his affiliated entities, to refrain from re-selling for a six month period any company common shares to be acquired by him in the Proposed Transactions; and (iii) the company has agreed not to conduct any equity offerings until after December 31 without the prior approval of the majority of its unaffiliated shareholders.
|
SMPL | Hot Stocks08:03 EDT Simply Good Foods: CFO Shaun Mara to leave company at end of November - The Simply Good Foods Company announced an executive leadership transition plan. Shaun Mara, Chief Administrative Officer and CFO, will step down from his role as of the fiscal year-end on August 26, and Todd Cunfer, Vice President Finance, will succeed him as CFO, effective August 27. Mara will assist with the executive team transition and continue to support the company on strategic initiatives in an advisory role through November 30. In addition, the company announced Robert Gandert, Chief Customer and Business Development Officer will step down from his role as of fiscal year-end on August 26, and Jill Short, Senior Vice President of Sales, will be promoted to Chief Customer Officer, effective August 27.
|
DRYS | Hot Stocks07:55 EDT Dryships trading halted, news pending
|
JCP | Hot Stocks07:34 EDT J.C. Penney now sees FY COGS up 30-50bps vs. 2016
|
JCP | Hot Stocks07:33 EDT J.C. Penney sees FY SSS down 1% to up 1% - The company has updated its cost of goods sold guidance and reaffirmed the remaining 2017 full year guidance. The fiscal 2017 full year guidance has been updated as follows: Comparable store sales: expected to be -1 % to +1 %; Cost of goods sold: now expected to be up 30 to 50 basis points versus 2016; SG&A dollars: expected to be down 1 to 2 % versus 2016.
|
JCP | Hot Stocks07:32 EDT J.C. Penney reaffirms FY EPS guidance
|
JCP | Hot Stocks07:32 EDT J.C. Penney CEO: Broader retail remains challenged
|
IONS GSK | Hot Stocks07:04 EDT Ionis Pharmaceuticals retains all rights to inotersen, IONIS-FB-L - Ionis Pharmaceuticals (IONS) reported that the company has retained all rights to inotersen and IONIS-FB-L. As part of a reprioritization of its pipeline and strategic review of its Rare Diseases business, GSK (GSK) declined its options on both drugs. Ionis plans to file for marketing authorization for inotersen this year to support a commercial launch of inotersen in 2018. Inotersen is a drug designed to treat patients with TTR amyloidosis. The first indication Ionis is pursuing for inotersen is to treat patients with polyneuropathy due to hereditary TTR amyloidosis. Ionis completed the Phase 3 NEURO-TTR study of inotersen in which the drug demonstrated significant benefit on both primary clinical endpoints of neurological disease progression and quality of life in patients with hATTR-PN.
|
STON | Hot Stocks07:03 EDT StoneMor Partners reports 770 total salespeople at July 31, up 81 y/y - StoneMor Partners provided additional data on the ongoing restructuring of its sales force. Total salespeople within the salesforce at July 31, 2017 numbered 770, which was 81 more than the prior year comparable period, while reflecting an increase of 17 from the 753 individuals reported at June 30, 2017. The number of salespeople who made a sale during the month of July 2017 was 660, a decrease of 1 from the 661 reported for July 2016. The number of salespeople who made a sale in July 2017 increased by 24 from the 636 who made a sale in June 2017.
|
FLY | Hot Stocks07:02 EDT Fly Leasing names Julie Ruehl as CFO - Fly Leasing announced it has appointed Julie Ruehl as its CFO, succeeding Gary Dales, who served as FLY's CFO for ten years. Prior to joining FLY, Ruehl previously served as the Vice President and Chief Accounting Officer for Big Heart Pet Brands and for its predecessor, Del Monte Corporation.
|
STX | Hot Stocks06:58 EDT ValueAct Capital raises stake in Seagate to 7.2% - In a regulatory filing, ValueAct Capital disclosed purchases of Seagate shares made between July 28 and August 9 that cumulatively raised the firm's stake in Seagate to 7.2%. ValueAct is now beneficial owner of 21M shares of Seagate common stock, representing approximately 7.2% of the company's outstanding common stock.
|
BBU | Hot Stocks06:46 EDT Brookfield Business Partners commences limited partnership unit NCIB - Brookfield Business Partners announced that the Toronto Stock Exchange has accepted a notice filed by Brookfield Business Partners of its intention to commence a normal course issuer bid for its limited partnership units. Brookfield Business Partners believes that in the event the units trade in a price range that does not fully reflect their value, the acquisition of units may represent an attractive use of available funds. Under the normal course issuer bid, the Board of Directors of the general partner of Brookfield Business Partners authorized the partnership to repurchase up to 5% of the issued and outstanding units, or 2,592,264 units. At the close of business on August 9, 2017, there were 51,845,298 units issued and outstanding. Under the normal course issuer bid, Brookfield Business Partners may purchase up to 14,580 units on the TSX during any trading day, which represents 25% of the average daily trading volume of 58,321 units on the TSX for the period February 1, 2017 to July 31, 2017. Repurchases are authorized to commence on August 15, 2017 and will terminate on August 14, 2018, or earlier should Brookfield Business Partners complete its repurchases prior to such date.
|
ATV | Hot Stocks06:39 EDT Acorn International sells majority stake in HJX business - Acorn International announced that the company recently reached an agreement to sell a majority stake in its HJX business to a third-party investor and operator. Specifically, the agreement includes the establishment of a joint venture that will be controlled and operated by such third party. Acorn's HJX business engages in direct sales of Ozing branded electronic learning devices incorporating mobile internet interactive features, such as online tutoring services. The partial divestiture of this business unit represents an exit of day-to-day management by Acorn from this business, allowing Acorn to focus on its already profitable businesses and brands, as well as on achieving profitable growth of new businesses within the Group. Under the terms of the agreement, the joint venture will help liquidate a large stock of HJX inventory, transition certain expenses on a pro rata basis to the joint venture and allow Acorn to divest day-to-day operational management to the third-party team. The joint venture is expected to be operational in the coming months.
|
GE | Hot Stocks06:38 EDT General Electric CEO John Flannery purchases 103,983 shares at $25.56 per share - General Electric CEO John Flannery disclosed in a regulatory filing that on August 8 he purchased 103,983 shares of GE at an average purchase price of $25.56 for his 401(k) retirement plan.
|
FELP | Hot Stocks06:36 EDT Foresight Energy sees FY17 sales volumes 20.5M-22.0M tons - Sees FY17 CapEx $70M-$77M. Sees FY17 adjusted EBITDA $285M-$310M.
|
GWR | Hot Stocks06:33 EDT Genesee & Wyoming reports July traffic up 14.1% year-over-year - Genesee & Wyoming reports traffic volume for July was 277,140 carloads, up 14.1%, compared with July 2016. G&W's July 2017 same-railroad traffic was 239,365 carloads, down 1.5%, vs. July 2016. In North American operations, traffic was 133,822 carloads, up 2.0% compared with July 2016, including carloads from acquisitions. On a same-railroad basis, North American traffic decreased 1.0%, primarily due to decreased agricultural products traffic, partially offset by increased metals and coal & coke traffic.
|
ICL | Hot Stocks06:29 EDT ICL signs contracts to supply 750,000 tonnes of potash to customers in India - ICL announced that it has signed several contracts to supply an aggregate 750,000 metric tonnes of potash, including options, to its customers in India. The contracts are for delivery between August 2017 and July 2018. The quantities stipulated in this year's contracts are similar to the amounts sold by ICL to its Indian customers in 2016. Selling prices are $13 per tonne higher than the price stipulated in the previous year's contracts.
|
ERF | Hot Stocks06:11 EDT Enerplus raises 2017 average production view to 84,000-86,000 BOE/d - Previous guidance was 81,000-85,000 BOE/d. Raises 2017 annual average liquids guidance to 39,500-41,500 barrels per day from 38,500 to 41,500 barrels per day.
|
FTS | Hot Stocks06:05 EDT Fortis announces termination of Consumer Share Purchase Plan - Fortis announced that it intends to terminate its Consumer Share Purchase Plan, or CSPP, effective September 13. The CSPP is available to residents of Newfoundland and Labrador and Prince Edward Island and facilitates the investment by participants of cash and the reinvestment of dividends, in each case, to purchase common shares of the Corporation. The CSPP exists alongside the Corporation's dividend reinvestment and share purchase plan, or DRIP, which provides the same benefits as the CSPP, but also provides for a 2% discount to the TSX market price for all common shares purchased by DRIP participants which are issued from treasury. The DRIP will continue to be available to all shareholders resident in Canada and the United States.
|
PRSC | Hot Stocks06:03 EDT Providence Service selling Mission Providence joint venture to Konekt - Providence Service is selling Mission Providence to Konekt Limited, a provider of return to work solutions throughout Australia. Mission Providence was formed in 2014 as a joint venture between Providence and Mission Australia to provide employment services under the Australian Government Department of Employment's jobactive programs. Konekt will acquire 100% of Mission Providence for total consideration of approximately $23M of which Providence is expected to receive approximately $17M for its 75% interest in the joint venture. For the twelve months ended December 31, 2016, Mission Providence generated revenues of $37M and a net loss of $11M. The joint ventures financial results are not consolidated with Providence's reported revenue, Adjusted EBITDA, or Adjusted Net Income. The transaction is expected to close in Q4.
|
TM... | Hot Stocks06:02 EDT Toyota, Intel, Ericsson form Automotive Edge Computing Consortium - DENSO Corporation (DNZOY), Ericsson (ERIC), Intel (INTC), Nippon Telegraph and Telephone Corporation (NTT), NTT DOCOMO (DCM), Toyota InfoTechnology Center and Toyota Motor Corporation (TM) announced that they have initiated the formation of the Automotive Edge Computing Consortium. The objective of the consortium is to develop an ecosystem for connected cars to support emerging services such as intelligent driving, the creation of maps with real-time data and driving assistance based on cloud computing.It is estimated that the data volume between vehicles and the cloud will reach 10 exabytes per month around 2025, approximately 10,000 times larger than the present volume. This expected increase will trigger the need for new architectures of network and computing infrastructure to support distributed resources and topology-aware storage capacity. The architectures will be compliant with applicable standards, which requires collaboration on a local and global scale. The consortium will focus on increasing network capacity to accommodate automotive big data in a reasonable fashion between vehicles and the cloud by means of edge computing and more efficient network design. It will define requirements and develop use cases for emerging mobile devices with a particular focus on the automotive industry, bringing them to standards bodies, industry consortiums and solution providers. The consortium will also encourage the development of best practices for the distributed and layered computing approach recommended by the members. In the coming months, the aforementioned companies will initiate activities to invite relevant global technology leaders and expand the consortium.
|
APEN | Hot Stocks05:43 EDT Apollo Endosurgery provides update, clarity to FDA letter to providers - Apollo Endosurgery provided an update and clarifications to a letter the FDA sent to Health Care Providers dated August 10, 2017 relating to potential risks with liquid-filled intragastric balloons, including the company's ORBERA intragastric balloon system. In relation to the ORBERA balloon, the facts are: ORBERA is approved by the FDA as safe and effective in assisting adult patients suffering from obesity with a body mass index of 30 to 40 in losing and maintaining weight. There have been five reported deaths of patients who had received the ORBERA intragastric balloon in four different countries since ORBERA's FDA approval in August of 2015. Apollo self-reported all five cases to the FDA as part of its Global Product Surveillance program. The FDA's letter to Health Care Providers does not indicate that the patient deaths were related to the ORBERA device or the insertion procedures. While the cause of death has not been provided or determined in all cases, Apollo has not received any communication or indication from the attending physicians or hospitals that the deaths have been due to the ORBERA device. Apollo has received no product liability-related claims in connection with these five cases. As stated in the ORBERA Directions For Use, in the period from January 1, 2006 through March 31, 2017, there have been 21 reported deaths of patients while they had an ORBERA, which is an incident rate of less than one one-hundredth of one percent of the more than 277,000 ORBERA balloons distributed in the same time period. Since receiving FDA approval in August 2015, the incident rate remains less than 0.01%. ORBERA remains the only intragastric balloon that meets the American Society of Gastrointestinal Endoscopy's, or ASGE, threshold standards for the treatment of obesity. Todd Newton, CEO of Apollo states: "Patient safety is a key priority in everything we do at Apollo Endosurgery and we take adverse event reporting obligations related to our products very seriously. The FDA letter is an important reminder to the physician community that obesity is a serious disease and many obese patients are affected by one or more co-morbid conditions due to their obesity. In our physician training, we are diligent to emphasize the factors that support the safe and effective use of ORBERA and we will continue to do so."
|
T | Hot Stocks05:34 EDT AT&T announces CWA-represented employees vote to ratify West wireline agreement - Leadership of the Communications Workers of America, or CWA, has notified AT&T that CWA-represented wireline employees have voted to ratify a four-year contract with Pacific Bell and Nevada Bell in the West region. The contract covers over 17,000 wireline and DirecTV employees in California and Nevada. The agreement was reached on July 14, after CWA-represented employees had narrowly failed to ratify a prior tentative agreement that had been reached in June. It was reached after extensive discussions between the Company, the CWA, and a federal mediator provided through the Federal Mediation and Conciliation Service. AT&T has reached, and union-represented employees have now voted to approve, 31 different labor agreements since 2015, covering about 145,000 employees.
|
GRAM | Hot Stocks05:32 EDT Grana y Montero extends mining services contract with Minera La Zanja for $30M - Grana y Montero announced that STRACON GyM, a subsidiary of Grana y Montero Group, formalized an extension to the contract signed in 2010 with Minera La Zanja SRL, a subsidiary of the company Buenaventura, for approximately $30M, to extend the term of mining services for an additional 12 months, counted from January 1 to December 31, 2018. La Zanja is an open pit gold and silver mine located in Cajamarca department, Pulan district, Peru, and is located between 3,200 and 3,600 m.a.s.l., which represents a technical and human challenge for the more than 500 workers working on the project.
|
COST BX | Hot Stocks05:30 EDT Costco elects Blackstone COO Hamilton James as chairman - Costco (COST) announced that Hamilton James has been elected as the chairman of the board. He is President, COO of Blackstone Group (BX), and a member of the board of its general partner, Blackstone Group Management L.L.C. He is also a member of Blackstone's Management Committee and sits on each of the firm's investment committees. Tony has been a director of Costco Wholesale since August 1988 and was its Lead Independent Director since 2005.
|